Samsung Bioepis releases Q3 2024 U.S. biosimilar market reportAs of June 2024, the FDA has approved a total of 57 biosimilars across 17 unique biological molecules; of the 57 approvals, 39 biosimilars have launched in the U.S. market. Hikma launches sodium acetate injection Sodium acetate injection had a market value of roughly $26 million in the 12 months ending May 2024, per IQVIA. Amneal intros Focinvez Focinvez 150 mg/50 mL single dose vial is an anti-nausea agent for emetogenic chemotherapy. Arunesh Verma joins Fresenius Kabi USA as president Verma succeeds John Ducker who will retire after 35 years with the company. Fresenius debuts subcutaneous formulation of biosimilar Tyenne Tyenne is an FDA-approved tocilizumab biosimilar that is available in both intravenous and subcutaneous formulations. Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz This expanded partnership solidifies Just – Evotec Biologics’ commitment to providing long-term commercial supply of biosimilars to Sandoz. Yaral Pharma becomes exclusive supplier of authorized generic levothyroxine sodium capsules Levothyroxine Sodium Capsules are used to treat hypothyroidism. CVS Health Foundation awards Women & Infants Hospital $1M The funding will support programs working to increase access to maternal health services in Rhode Island. Video: 3 minutes with Shoppers Drug Mart's Jeff Leger Leger shared the exciting news that, unlike the United States, Canada is embracing expanded scope of practice for retail pharmacy. FDA gives Lupin tentative approval for generic Trijardy Trijardy contains three diabetes medications: empagliflozin, linagliptin and metformin hydrochloride. First Previous 59 60 61 62 63 Next Last
